Prognostic variability among nonsmall cell lung cancer patients with pathologic N1 lymph node involvement: Epidemiological figures with strong clinical implications

Cancer

Volumn 107, Issue 4, 2006, Pages 793-798

  Caldarella, Adele ^a,b   Crocetti, Emanuele ^a   Comin, Camilla E ^b   Janni, Alberto ^c   Pegna, Andrea Lopes ^c   Paci, Eugenio ^a  

^a CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Lung cancer; Lymph node station; Prognosis; Tumor lymph node metastasis staging

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ITALY; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SEX DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 33747194093     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22072     Document Type: Article

References (20)

1. Parkin DM, Whelan SL, Ferlay J, Thomas DB. Age-standardized and cumulative incidence rates: trachea, branchus and lung. In: Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, editors. Cancer Incidence in Five Continents. Vol. VIII. Lyon, France: International Agency for Research on Cancer; 2002:579-581.
2. Rosso S, Spitale A, Balzi D, Franceschi S, Zanetti R. Estimate of cancer incidence in Italian regions, 2001. Epidemiol Prev. 2004;28(4-5):247-257.
3. Watanabe Y. TNM classification for lung cancer. Ann Thorac Cardiovasc Surg. 2003;9:343-350.
4. Yano T, Yokoyama H, Inoue T, et al. Surgical results and prognostic factors of pathologic N1 disease in non-small cell carcinoma of the lung. J Thorac Cardiovasc Surg. 1994;107:1398-1402.
5. Osaki T, Nagashima A, Yoshimatsu T, et al. Survival and characteristics of lymph node involvement in patients with N1 non-small cell lung cancer. Lung Cancer. 2004;43:151-157.
6. Rea F, Marulli G, Callegaro D, et al. Prognostic significance of main bronchial lymph node involvement in non-small cell lung carcinoma: N1 or N2? Lung Cancer. 2004;45:215-220.
7. Okada M, Sakamoto T, Yuki T, et al. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors. J Thorac Cardiovasc Surg. 2005;129:825-823.
8. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest. 1997;111:1718-1723.
9. Mountain CF. Revision in the international system for staging lung cancer. Chest. 1997;111:1710-1717.
10. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
11. Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg. 1978;76:832-839.
12. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;50:163-170.
13. Cox DR. Regression models and life tables. J R Stat Soc B. 1972;34:187-220.
14. Riquet M, Manac'h D, Le Pimpec-Barthes F, et al. Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung. Ann Thorac Surg. 1999;67:1572-1576.
15. Yoshino I, Nakanishi R, Osaki T, et al. Unfavorable prognosis of patients with Stage II non-small cell lung cancer associated with macroscopic nodal metastases. Chest. 1999;116:144-149.
16. Asamura H, Suziki K, Kondo H, et al. Where is the boundary between N1 and N2 stations in lung cancer? Ann Thorac Surg. 2000;70:1839-1846.
17. Ueda K, Kaneda Y, Sakano H, et al. Independent predictive value of the overall number of metastatic N1 and N2 stations in lung cancer. Jpn J Thorac Cardiovasc Surg. 2003;51:297-301.
18. van Velzen E, Snijder RJ, de la Riviere AB, et al. Type of lymph node involvement influences survival rates in T1N1M0 non-small cell lung carcinoma. Chest. 1996;110:1469-1473.
19. Keller SM, Vangel MG, Wagner H, et al. Prolonged survival in patients with resected non-small call lung cancer and single-level N2 disease. J Thorac Cardiovasc Surg. 2004;128:130-137.
20. Watanabe Y. TNM classification for lung cancer. Ann Thorac Cardiovasc Surg. 2003;9:343-350.